DarioHealth Corp. DRIO Cash Flow

Dariohealth corp. (DRIO)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12
Cash flows from operating activities:
Net loss
-9,892	-4,173	-2,805	-5,382	-5,376	-4,983	-4,063	-5,838	-2,919	-3,265	-2,973	-4,092	-5,413	-3,861	-611	-4,047	-2,368	-1,672	-1,828	-2,004	-1,638	-3,562	-3,077	-3,254	-2,984	54	-3,472	-5,286	-5,227	-1,192	-3,056	-867	-570
Adjustments required to reconcile net loss to net cash used in operating activities:
Stock-based compensation, common stock, and stock instead of cash compensation to directors, employees, consultants and service providers
6,356	329	618	1,053	257	474	633	2,421	230	762	621	856	1,585	124	246	344	324	-	-	117	125	170	323	690	509	-	-	-	-	-	-	-	-
Stock-based compensation, warrants and restricted shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	743	1,150	1,712	-	-	-	-
Stock-based compensation, warrants and restricted shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	126
Stock-based compensation, Common Stock to service providers and warrant
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	44	41	448	0	0	0	0	0	0	0	101
Depreciation
46	45	45	47	46	47	59	48	53	40	54	58	43	114	82	89	102	87	85	84	79	88	103	160	198	261	264	197	117	17	3	2	1
Change in operating lease right of use assets
-80	-	-	-	-23	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease exchange rate differences
-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase in trade receivables
102	153	241	26	84	-206	26	148	-82	-137	47	-110	256	-31	257	0	0	-	-	-	22	-	-	0	0	-	-	-	-	-	-	-	-
Decrease (increase) in accounts receivables and prepaid expenses and long-term assets
-227	-	-	-	46	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in accounts receivables and prepaid expenses
-	-	-	-	-	-	-34	-9	-38	-165	118	-64	210	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease (increase) in other accounts receivable and prepaid expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-74	-10	529	76	66	-22	-41	3	-193	73	-158	-52	200	8	314	78	-20	19
Decrease (increase) in inventories
-193	-59	-346	-105	547	357	-148	256	-272	259	207	-132	-39	-230	107	6	404	285	108	-27	0	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in trade payables
-417	250	-978	-593	403	371	125	966	-740	-132	998	-499	-328	785	22	449	-422	109	20	18	145	-553	328	90	-51	-4	-96	243	128	-53	87	120	-20
Increase in other accounts payable and accrued expenses
-523	951	-449	-814	683	520	-482	720	219	143	-724	653	262	95	45	-6	244	160	105	-45	-118	65	101	417	-242	386	-133	180	170	-40	204	-21	85
Increase in deferred revenues
42	-	-	-	560	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrants to purchase shares of Common Stock
-	-	-	-	-	0	0	0	-1	-1	-1	-25	1,195	678	-2,788	1,418	432	-	-	-	-	950	-2,606	-396	-142	-	-	-	-	-	-	-	-
Increase in deferred revenues
-	-	-	-	-	-	-	50	0	-	-	-	-	0	0	-8	-23	-23	-24	22	32	24	0	0	0	-	-	-	-	-	-	-	-
Change in operating lease liability
-101	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Decrease in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	753	-526	150	-	-	-	-	-	-	-1,664	-2,136	400	-2,033	5	21
Others
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,063	-1,382	-1,307	-1,525	-2,413	-1,750	-2,081	-2,337	-2,127	-2,453	-2,049	-972	-	-	-	-
Net cash used in operating activities
-4,545	-2,852	-3,382	-5,502	-3,989	-3,439	-3,237	-2,028	-2,766	-2,396	-2,397	-2,743	-3,083	-1,859	-2,722	-1,693	-2,105	-	-	-	-	-	-	-	-	-	-	-	-	-	-723	-479	-316
Cash flows from investing activities:
Maturities (investment) of restricted bank deposit
-	-	-	-	-	-	2	-6	-70	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds of maturities of short-term bank deposit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	-1	-72	-158	0	-	-	-	-	-	-	-	-
Investment in deposit
-	-	-	-	-	-4	5	-3	3	-	-	-	-	-5	0	7	-8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Investment in restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13	-	-	-	0	-	-	-	0	13	0	0	0
Maturity of short-term bank deposits
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-21	21	14	0	12	0	0	0
Investment in lease deposits
-	-	-	-	-	-	-	-	-	-	-	-2	9	-	-	-	-	-	-	-	-	-	-	-	-	57	0	105	0	0	19	0	0
Maturity of (investment in) lease deposits
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-7	0	-2	8	0	-14	14	92	0	9	0	0	0
Purchase of property and equipment
28	19	8	26	45	22	26	11	12	131	33	31	0	402	160	211	35	40	24	10	36	344	69	34	116	92	162	684	462	500	11	12	9
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-48	-16	-20	-29	-304	5	-14	-116	-156	-155	-867	-462	-	-	-	-
Net cash used in investing activities
-28	-16	-19	-33	-45	-92	-33	-2	55	-142	-39	-29	-9	-387	-315	-218	-27	-	-	-	-	-	-	-	-	-	-	-	-	-	-31	-12	-9
Cash flows from financing activities:
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	20	190	533	0	0	0	0	0	161	189	66	31	195	0	-	-	-	-
Proceeds from issuance of Common Stock and warrants, net of issuance cost
-	-	-	-	-	-	-	-	6,034	-6	4,800	3,853	4,816	0	0	0	7,538	5,119	0	0	1,956	0	0	-59	3,813	12	19	9,453	498	2,384	568	0	915
Net cash provided by financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,874	2,325	453	1,956	0	4,096	102	4,002	78	50	9,648	498	-	-	-	-
Proceeds from exercise of options and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	20	190	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Net cash provided by financing activities
-	-	-	-	-	3,023	9,686	0	6,034	-6	4,800	3,853	4,816	0	0	20	7,728	-	-	-	-	-	-	-	-	-	-	-	-	-	568	0	915
Decrease in cash, cash equivalents and short-term restricted bank deposits
-4,573	15,821	-3,401	1,023	-4,034	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	3,323	-2,544	2,364	1,081	1,724	-2,246	-3,037	-1,891	5,596	763	927	-874	402	-2,717	2,351	-1,993	1,549	-2,205	-2,558	6,732	-936	410	-187	-491	590
Conversion of liability related to warrants into Common Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	13	18	385	0	-	-	-	-
Receivable on account of shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-19	31	0	-	-	-	-
Receivable on account of shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,050	-70	70
Purchase of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	2	-5	29	-15	267	52	4	35	-10	-291	330	83	0	0	0
Conversion of liability related to warrants to Common stock as a result of 2011-2012 Private Placement round warrants conversion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9	13	18	385	0	-	-	-	-
Conversion of Series A Preferred Stock to Common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	2,277	0	-1	299	102	46	-9	9	0	-	-	-	-	-	-	-	-
Reclassification of warrants from liability to equity
-	-	-	-	-	-	-	-	-	-	-	-	8,655	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment for directors and consultants under Shares for Salary Program
-	-	-	-	-	-	85	116	85	-	-	-	183	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment for directors and employees under Stock for Cash Program
-	-	-	-	-	-	-	-	-	-	-	-	-	-	52	51	51	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payment for executives and directors under Salary Program
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	112	82	110	0	-	-	-	-	-	-	-	-	-	-	-	-